Suppr超能文献

FDA 医疗器械顾问委员会会议期间的投票行为。

Voting behavior during FDA Medical Device Advisory Committee panel meetings.

机构信息

Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America.

Department of Dermatology, Columbia University Medical Center, New York, NY, United States of America.

出版信息

PLoS One. 2022 Jun 24;17(6):e0267134. doi: 10.1371/journal.pone.0267134. eCollection 2022.

Abstract

OBJECTIVES

During premarket review, the US Food and Drug Administration may ask its Medical Device Advisory Committee (MDAC) Panels to assess the safety and effectiveness of medical devices being considered for approval. The objective of this study is to assess the relationship, if any, between individual votes and Panel recommendations and: (1) the composition of Panels, specifically the expertise and demographic features of individual members; or (2) Panel members' propensity to speak during Panel deliberations.

METHODS

This was a retrospective cohort study of routinely collected data from voting members of MDAC panels convened between January 2011 to June 2016 to consider premarket approval. Data sources were verbatim transcripts available publicly from the FDA. Number of words spoken, directionality of votes on device approval, profession, and demographics were collected.

RESULTS

658,954 words spoken by 536 members during 49 meetings of 11 Panels were analyzed. Based on multivariate analysis, biostatisticians spoke more (+373 words; P = 0.0002), and women (-187 words; P = 0.0184) and other non-physician voting members less (-213 words; P = 0.0306), than physicians. Speaking more was associated with abstaining (P = 0.0179), and with voting against the majority (P = 0.0153). Non-physician, non-biostatistician members (P = 0.0109), and those having attended more meetings as a voting member (P = 0.0249) were more likely to vote against approval. In bivariable analysis, unanimous Panels had a greater proportion of biostatisticians (mean 0.1580; 95% CI 0.1237-0.1923) than non-unanimous Panels (0.1107; 95% CI 0.0912-0.1301; p = 0.0201).

CONCLUSIONS

Panelists likely to vote against the majority include non-physician, non-biostatisticians; experienced Panelists; and more talkative members. The increased presence of biostatisticians on Panels leads to greater voting consensus. Having a diversity of opinions on Panels, including in sufficient numbers those members likely to dissent from majority views, may help ensure that a diversity of opinions are aired before decision-making.

摘要

目的

在美国食品和药物管理局(FDA)进行上市前审查期间,其医疗器械咨询委员会(MDAC)小组可能会被要求评估正在考虑批准的医疗器械的安全性和有效性。本研究的目的是评估个别投票与小组建议之间的关系,如果有的话,以及:(1)小组的组成,特别是小组成员的专业知识和人口统计学特征;或(2)小组成员在小组审议期间发言的倾向。

方法

这是一项回顾性队列研究,对 2011 年 1 月至 2016 年 6 月期间召开的 MDAC 小组会议的投票成员进行了常规数据收集,以考虑进行上市前批准。数据来源是 FDA 公开提供的逐字记录。收集了发言人数、医疗器械批准投票的方向、专业和人口统计学特征。

结果

对 11 个小组的 49 次会议上 536 名成员的 658954 个单词进行了分析。基于多变量分析,生物统计学家发言更多(+373 个单词;P=0.0002),女性(-187 个单词;P=0.0184)和其他非医师投票成员发言更少(-213 个单词;P=0.0306)。发言更多与弃权有关(P=0.0179),并且与投票反对多数意见有关(P=0.0153)。非医师、非生物统计学家成员(P=0.0109)和作为投票成员参加更多会议的成员(P=0.0249)更有可能投票反对批准。在双变量分析中,一致的小组中生物统计学家的比例更高(平均值为 0.1580;95%CI 0.1237-0.1923),而非一致的小组则更低(0.1107;95%CI 0.0912-0.1301;P=0.0201)。

结论

可能投票反对多数意见的小组成员包括非医师、非生物统计学家;经验丰富的小组成员;以及更健谈的成员。小组中生物统计学家的增加导致投票共识增加。在小组中拥有不同的意见,包括足够数量的可能与多数意见相左的成员,可能有助于确保在做出决策之前发表不同的意见。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d84/9231736/04b1c3a7541f/pone.0267134.g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验